HLA typing was carried out in 132 patients with rheumatoid arthritis (RA) with long term follow up, and special attention was focused on rheumatoid factor negative patients. The patients were divided into four groups: 55 patients with a seropositive RA and a positive antiperinuclear factor (group A); 39 seropositive patients but a negative antiperinuclear factor (group B); 14 patients consistently seronegative for 3-28 years (mean 11-8 years) but positive for antiperinuclear factor (group C); patients consistently negative for 3-28 years (mean 11-8) and also negative for antiperinuclear factor (group D). The prevalence of HLA-DR4 was 31/55 (56%), 29/39 (74%), 10/14 (71%), and 9/24 (37%) for groups A, B, C, and D respectively, and in all groups was significantly higher than in 277 healthy controls (55/ 277, 20%). No significant difference was found between seropositive (groups A and B) and seronegative (groups C and D) patients, but groups A, B, and C had higher prevalences than group D. It is concluded that in seronegative RA HLA-DR4 is preferentially associated with the antiperinuclear factor positive group.
Accepted for publication 10 March 1989 Although an association between HLA-DR4 and adult onset rheumatoid arthritis (RA) has been firmly established,'-9 it is uncertain whether the same DR4 association exists in subgroups of patients with RA.2 3 5 10-13 Rheumatoid factor negative patients with RA diagnosed according to the American Rheumatism Association criteria"4 form a clinical subgroup that can be subdivided into antiperinuclear factor positive (RF-APF+) and antiperinuclear factor negative (RF-APF-) patients. The antiperinuclear factor is highly specific for RA, but its sensitivity is rather low.'1"7 We recently showed that in seronegative RA the presence of antiperinuclear factor is related to a more severe form of the disease. ' 
Discussion
In this study of patients with RA an increased prevalence of HLA-DR4 was seen in those positive for rheumatoid factor with or without antiperinuclear factor and those negative for rheumatoid factor but positive for antiperinuclear factor compared with patients negative for both antibodies. We recently reported that the presence of antiperinuclear factor in seronegative RA is an indication of more severe disease.'8 The immunogenetic heterogeneity in seronegative RA with and without antiperinuclear factor perhaps indicates that there is an immunogenetic basis for the difference in severity of disease. There are conflicting opinions about the relation between rheumatoid factor negative RA and HLA-DR4.2 3 1013 Some authors describe a normal prevalence of HLA-DR4 in seronegative RA2 3 and a significantly increased prevalence in seropositive RA. t-9
On the other hand, other studies concluded 
